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ABSTRACT
We performed parallel array comparative genomic hybridization and
array expression analysis of the 12p11-p12 amplicon in human testicular
seminomas and an ovarian carcinoma cell line using an expressed se-
quence tags (ESTs) array spotted with 8254 ESTs. The data were normal-
ized using a robust statistical modeling and the significance inferred from
the local SD. We identified two ESTs within the chromosomal amplicon
that were amplified and overexpressed in >75–100% of analyzed tumors
with the 12p11-p12 amplicon. These sequences, belonging to coding re-
gions of two novel genes designated here as GCT1 and GCT2, were broadly
expressed in a panel of human tissues, including testis and ovary. GCT1
and GCT2 were overexpressed in 92 and 71%, respectively, of a panel of
seminomas tested. Combined array comparative genomic hybridization
and array expression analysis is a valid approach for gene discovery in
large chromosomal amplicons.
INTRODUCTION
Chromosomal amplification is a common mechanism by which
genes achieve overexpression in tumors. Identifying amplified se-
quences thus provides a starting point for discovering genes involved
in cancer biology (1, 2). In recent years, chromosomal CGH3, where
test (tumor) and reference (normal) gDNAs are cohybridized to nor-
mal metaphase chromosomes, has been used to identify DNA copy
number variations across the genome at a mapping resolution of 20
Mb (3). In contrast, cohybridization of test and reference gDNAs to
arrays spotted with genomic clones (genomic arrays) has been suc-
cessfully used to identify DNA copy number variation of shorter
(100 Kb) genomic sequences (4–8). EST array CGH, where test
gDNAs alone (9) or test and reference gDNAs together are hybrid-
ized, can detect genomic amplification of expressed sequences (10,
11). By hybridizing test and reference cDNAs to the same EST array
in parallel, the variation in expression of the amplified genes can
simultaneously be analyzed. Thus, powerful high throughput tech-
niques are now available to rapidly screen tumors for gene amplifi-
cation and expression leading to gene discovery and new insights into
mechanisms of carcinogenesis.
Human GCTs are a heterogeneous group of neoplasms that present
in the testis, ovary, and at extragonadal sites. Cytogenetic analysis of
TGCTs and cell lines derived from them has shown that overrepre-
sentation of 12p, either as one or more copies of i(12p) or as tandem
amplification of 12p, occurs in virtually all tumors and comprises the
hallmark of this tumor type (12). 12p amplification has also been
observed in a broad spectrum of human neoplasms, including ovarian
tumors (13)4, indicating that one or more amplification targets of
relevance to tumorigenesis per se reside on this chromosomal arm. In
GCTs and other tumors, in addition to the amplification of the entire
12p, a subregional amplification of 12p11-p12 was identified, which
has been suggested to be associated with tumor progression (14).
Several of the known genes mapped to 12p have been shown to be in
increased copy number at the genomic level in TGCTs; however, their
possible overexpression and role in tumorigenesis has not been fully
established (15–19). Here, we report parallel array CGH and array
expression analysis of the 12p11-p12 amplicon using an array spotted
with 8254 ESTs. We normalized the array data using a robust statis-
tical modeling (20). The significance of differences in the copy
number and level of expression was inferred from the empirically
determined local SD of the log ratios. We identified two amplified and
overexpressed ESTs mapped to 12p11-p12. These ESTs were in the
coding region of novel genes of unknown function, designated here as
GCT1 and GCT2. This study shows that combined array CGH and
array expression analysis, in conjunction with the data analysis algo-
rithm used here, is a valid approach to the molecular dissection of
chromosomal amplification in cancer.
MATERIALS AND METHODS
Tumor Specimens, Cell Lines, and Chromosomal CGH. The normal
testis and TGCT biopsies studied were ascertained by the Department of
Pathology and the Laboratory of Cancer Genetics at the Memorial Sloan-
Kettering Cancer Center. They comprised 24 seminomas and 37 nonsemino-
mas. All of the 12 TGCT cell lines used in these studies (CL-268A, CL-154A,
CL-169A, CL-169A, CL-318C, CL218A, CL-354B, CL-577M-Lu, CL-
577M-F, CL-2102E-P, CL-2102ER, Tera1, and Tera-2) were of nonseminoma
derivation and were either publicly available (CL-577M-Lu, CL-577M-F,
CL-2102E-P, CL-2102ER, Tera1, and Tera-2) or were derived at the Labora-
tory of Cancer Genetics, Memorial Sloan-Kettering Cancer Center from biopsy
samples. The OCCL cell line was provided by Dr. Samuel C. Mok. This cell
line was developed from a 71-year-old patient with stage III grade 2 ovarian
papillary serous adenocarcinoma. Chromosomal CGH was performed as de-
scribed previously (21).
RNA Preparation. RNA was isolated from normal testis, tumor tissues,
and cell lines using RNeasy mini or midi kits and following manufacturer-
recommended protocols (Qiagen, Valencia, CA). Contaminating DNA was
removed by digestion with RNase-free DNase (Life Technologies, Inc., Grand
Island, NY) followed by cleaning using an RNeasy cleanup kit (Qiagen). To
further rule out DNA contamination, 0.5 g of cleaned RNA was subjected to
RT-PCR using -actin-specific primers. RNA was considered DNA-free only
if no product appeared in an identical control reaction where the reverse
transcriptase (Superscript II; Life Technologies, Inc., Grand Island, NY) has
been omitted. RNA quality and quantity were determined by measuring the
absorbance at 260 and 280 nm and by denaturing gel electrophoresis.
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EST Arrays. The EST arrays used were generated at the AECOM mi-
croarray facility (22). Per printing, 8254 T3/T7 PCR-amplified human Image
clones (ESTs) were pin-printed on poly-L-lysine or amino-silane (CMT-GAPS;
Corning, Corning, NY)-coated slides. A Toto-3 dye (Molecular Probe, Eugene,
OR) staining of one slide per printing was performed routinely to monitor the
quality of printing.
Array Preparation and Prehybridization. Array slides were prepared for
hybridization as described in the AECOM microarrray facility URL.5 For array
CGH, the slides were prehybridized for 1–5 h with 20 l of prehybridization
solution consisting of 35% formamide, 4 saline-sodium phosphate-EDTA,
0.5% SDS, 2.5 Denhart, 0.2 mg/ml Salmon sperm DNA (Sigma, St. Louis,
MO), and 1 g/ml Cot-1 DNA (Life Technologies, Inc.). For expression array,
the slides were prehybridized for 1 h with cDNA hybridization buffer (Geni-
sphere, Hatfield, PA) plus 0.1% BSA before cDNA hybridization and for
another hour with the dye hybridization buffer (Genisphere, Hatfield, PA) plus
0.1% BSA before tagged dye hybridization.
gDNA Labeling and Array Hybridization. A total of 5–10 g of test and
reference gDNAs was digested with DpnII or AvaI restriction enzymes for 1 h,
purified using a PCR clean-up kit (Promega, Madison, WI), and extracted in 50
l of water. Digested DNAs were concentrated, if necessary, by ultrafiltration
(Microcon YM-30, Amicon; Millipore, Bedford, MA). Equal amounts of test
and reference DNAs (1.8–2.2 g) were labeled in 50 l with 20-g random
nonamers (Genelink), 50-unit 3-5exo minus Klenow fragment (New England
Biolabs, Beverly, MA), dATP, dGTP, dCTP (120 M each), and dTTP (60
M). Cy3-dUTP or Cy5-dUTP (60 M; Amersham, Piscataway, NJ) were
added to the test and reference reactions, respectively. The reaction mixtures
were pooled, purified, and concentrated by ultrafiltration (Microcon YM-30,
Amicon; Millipore) and adjusted to contain 35% formamide, 0.5% SDS, 2.5
Denhart, and 0.25 saline-sodium phosphate-EDTA in a final volume of 19
l. To this, 1 l of block solution (10) was added. The probe was then
denatured for 2 min at 100°C, annealed with Cot-1 DNA for 15 min at 50°C,
and hybridized to the array for 12–15 h at 50°C. The slides were washed for
5 min at 55°C in 1 SSC, 0.1% SDS, followed by three washes at room
temperature: 10 min in 0.2 SSC, 0.1% SDS; 20 min in 0.2 SSC; and twice
20 min in 0.1 SSC. The slides were then centrifuged for 5 min at 900  g
before scanning.
RNA Reverse Transcription, cDNAs Labeling, and Array Hybridiza-
tion. Equal quantities (8–10 g) of test and reference RNAs were reverse
transcribed, labeled with the 3DNA Expression Array Detection kit (Geni-
sphere, Hatfield, PA), and hybridized to the arrays as described in the manu-
facturer’s protocol. After reverse transcription, the cDNA pellets were dried
with compressed N2 followed by incubation at 37°C for 3–5 min.
Array Image Analysis. The arrays were scanned with either the AECOM
(22) or an Axon dual color laser scanner (GenePix 4000A; Axon, Union City,
CA). At the time of the scanning, the laser power was adjusted to have 5%
features saturated; the digitized Cy3 and Cy5 signals were pseudocolored in
green and red, respectively (GenePix Pro 3.0; Axon). After gridding, each dot
on the 24-bit ratio image was visually inspected and, if necessary, unsatisfac-
tory dots were manually flagged. A GenePix results (*.gpr) file of the raw data
(F635 median-B635 median, F532 median-B532 median) was used for addi-
tional data analysis as described.
Copy Number Estimation by Southern Blot Analysis. For each tumor
and control, 5 g of gDNA were digested with EcoRI, separated by electro-
phoresis, transferred to nylon membranes (Sure Blot; Intergen, Purchase, NY),
and hybridized with specific probes for GCT1 (R44861) and GCT2 (R70583).
Signals were quantified using ImageQuant (Molecular Dynamics, Sunnyvale,
CA), and values for GCT1 and GCT2 were normalized with the values
obtained for D2S48 (ATCC 59212).
Semiquantitative RT-PCR Analysis of RNA Expression. A multiple
tissue cDNA panel consisting of 16 normal human tissues generated using
normalized first strand poly(A) RNA (Clonetech, Palo Alto, CA) was used
for analysis of normal expression pattern of GCT1 and GCT2. Total RNA
isolated from normal testis, tumor tissues, and the tumor cell lines was reverse
transcribed using random primers and Pro-Star first strand RT-PCR kit (Strat-
agene, La Jolla, CA) following manufacturer-recommended protocol. Semi-
quantitative analysis of gene expression was performed by 26–28 cycles of
multiplex RT-PCR with -actin plus GCT1 or GCT2-specific primers. Primers
for RNA amplification were selected to span at least two exons to rule out
gDNA contamination. GCT1-forward 5-TGTTGCAGCAGTGGAAACTC-3
(580–599) and GCT1-reverse 5-ACCAACTGGGTAGGTGTGGA-3 (822–
841) amplified 262 bp of cDNA. GCT2-forward 5-GATCTCCTTAACGGA-
CACGC-3 (96–115) and GCT2-reverse 5-TCAAAGGCCAACCAATA-
AGG-3 (327–346) amplified 251 bp of cDNA. The PCR products were run on
1.5% agarose gels, visualized by ethidium bromide staining, and quantitated
using a Kodak digital image analysis system. The values obtained for each
gene in four normal testis RNA samples were used to calculate the SD, and
their mean was used to calculate the ratio (test/normal). A gene was considered
overexpressed if the ratio was (1.00  2SD).
RESULTS
Mapping of the Sequences Spotted on the Arrays. Among the
8254 ESTs spotted on the array, 252 were singletons, whereas the
remaining were included in 7366 UniGene clusters, including 6167
that had mapping information. Of these, 352 were mapped to chro-
mosome 12, 118 that were assigned to 12p, and 33 that were further
assigned to 12p11-p12. On the basis of the comparison of sequences
mapped to 12p in several databases (UniGene, UniSTS, GeneMap’98,
GeneMap’99, GeneBridge 4, OMIM Gene Map, the working draft
sequence build 22, the AECOM 12p map, and TIGR6), we estimated
that 12p contains coding sequences of 400 genes.7 The EST array
used therefore represents approximately one-third of the 12p genes.
Chromosomal CGH Analysis. Thirty-eight TGCT biopsy sam-
ples (10 seminomas and 27 nonseminomas) and the OCCL were
subjected to chromosomal CGH analysis. The 12p amplification status
in 34 of these tumors by CGH has been published elsewhere (23).
High-level amplification at 12p11-p12 was observed in 4 seminomas
(187A, 192A, 287B, and 427A) and the OCCL cell line (Fig. 1).
Array CGH Analysis. We performed array CGH analysis on the
DNAs from the five samples that showed 12p11-p12 amplification by
chromosomal CGH. As controls, we similarly analyzed tumor 227A,
a seminoma that did not show 12p11-p12 amplification and placenta.
Test (tumor) and reference (placenta) gDNAs were labeled with Cy3
and Cy5, respectively, and cohybridized to the EST array. The signals
obtained after laser excitation of the dyes were digitized (Fig. 2), and
the raw data (median feature pixel intensity with the median local
background intensity subtracted at each wavelength) were then sub-
jected to statistical analysis. To correct for systematic errors intro-
duced by the intensity-dependent dye efficiencies, the hybridization
signal data from each slide were normalized using a local regression
of the log-ratio variable Y  log2(G/R) versus the log-product
X  log10(R  G)/2 (R and G represent the intensities of the Cy3 and
Cy5, respectively; Ref. 20). Examples of pre- and postnormalized data
are shown in Fig. 3, A and B. In practice, the noise structure and
magnitude of the signals varied from slide to slide, as can be seen by
5 Internet address: sequence.aecom.yu.edu/bioinf/funcgenomic.html.
6 Internet address: www.tigr.org.
7 V. Bourdon, et al., manuscript in preparation.
Fig. 1. Chromosomal CGH analysis. gDNA
from tumor (green) and placenta (red) were cohy-
bridized to metaphase chromosomes. Four semino-
mas (187A, 287B, 427A, and 192A) and the OCCL
cell line showed amplification at 12p11-p12.
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the variation in the shapes of the point clouds (Fig. 3A). It was
therefore important to construct an indicator to identify ESTs that
exhibited significant signal deviation from normal in a given slide. To
this end, we computed the intensity-dependent (local) variance
(XN)2 from a local regression of YN2 versus XN after normalization
(XN and YN represent the normalized X and Y variables). We ob-
served that the variable |YN| /(XN) closely followed a Gaussian
distribution in the control experiments, as shown by the straight
quantile-quantile plot (Fig. 3C). As expected for tumor versus refer-
ence comparisons, these distributions were slightly longer-tailed on
one side of the plot, reflecting biological amplification (indicated by
the arrows in Fig. 3C). Because the bulk of the distributions were
nearly Gaussian, it was felt justified to attribute significance to am-
plified or overexpressed ESTs according to the values of YN/(XN)
(LR/SD), independently for each slide.
After preprocessing the data as described above, an EST was
considered amplified when the value LR/SD was 3 (0.1% probabil-
ity of a false-positive call). Among the 8254 sequences on the array,
111 were amplified in one or more of the tumors tested. Of these, 57
(51%) were mapped to chromosome 12, and of these, 49 (86%) were
mapped to 12p. This number was highly significant when compared
with the number of amplified ESTs mapped to regions of the genome
other than 12p, thus ruling out the possibility of finding the 12p-
amplified ESTs by chance alone (P  10-10). When selecting only for
sequences showing amplification in 75% of the acceptable hybrid-
ization data from the five tumors tested, 19 sequences were identified,
of which 13 (68%) were mapped to 12p11-p12 (Fig. 2). None of these
ESTs showed a significant amplification in the control experiments,
which comprised three placenta versus placenta and the placenta
versus tumor 227A hybridizations (LR/SD  1.13).
Array Expression Analysis. We were able to isolate good quality
RNA from the four GCTs tested by array CGH (187A, 192A, 287B,
and 427A). Test (tumor) and reference (normal testis) RNAs were
reverse-transcribed, labeled, and cohybridized to the EST array as
described above. The data were normalized also as described above,
and the expression data for the 13 amplified ESTs mapped to 12p11-
p12 were analyzed (Fig. 2). Considering ESTs to be overexpressed
when the LR/SD was 2 in 75% of the acceptable hybridization
data from the four tumors (2.3% probability of a false-positive call),
we found two amplified and overexpressed sequences belonging to
the UniGene8 clusters Hs.22595 and Hs.62275. We designated these
genes as GCT1 and GCT2. Neither of these amplified and overex-
pressed ESTs showed significant overexpression in five independent
control experiments comprising normal testis versus normal testis
RNA (cDNA) hybridizations (LR/SD  1.3).
Southern Blot Analysis. We performed Southern blot analysis of
the five tumors that were subjected to array CGH, using GCT1 and
GCT2 probes, to confirm their genomic copy number status (Fig. 4).
The GCT1 and GCT2 probes were selected from the 3 end of the their
cDNAs, and the probe D2S48, mapped to chromosome 2, was used to
quantify the amount of DNA loaded. The amplification of GCT1 and
GCT2 observed by array CGH was confirmed by Southern blot
analysis, their copy number ranged from 10.2 to 26.2.
Expression of GCT1 and GCT2 in Normal and Tumor Tissues.
GCT1 has 17 exons spanning 32.8 Kb of genomic sequence. The
ESTs were assembled in a UniGene (24) cluster Hs.22595 and a TIGR
cluster THC847867 (THC Version 8.0; Ref. 25) and included cDNA
derived from germ cells, testis, and GCTs. The corresponding human
hypothetical protein sequence (DKFZp434L032.1, GenBank acces-
sion T46457) showed 70–88% identity with protein sequences of
different species grouped in a tentative orthologue group TOGA96125
(TOGA9 version 5.0). Blast analysis of this protein sequence against
FlyBase10 showed 40% identity with the Mat89Bb gene (ovary2).
This gene, located on the right arm of the third chromosome (89B16-
8 Internet address: www.ncbi.nlm.nih.gov/UniGene.
9 Internet address: www.tigr.org/tdb/toga/toga.shtml.
10 Internet address: flybase.bio.indiana.edu.
Fig. 2. Combined CGH and Expression EST array analysis. A, pseudocolored views of an identical portion of the EST arrays (392 of the 8254 features spotted). Left: gDNA from
tumor 187A (green) and placenta (red) were cohybridized. Right: cDNAs from tumor 187A (green) and normal testis (red) were cohybridized. In both panels, the green box indicates
the common amplified and overexpressed EST. B, summary of the results. Green boxes represent the ESTs considered to be amplified and overexpressed after statistical analysis.
Thirteen were amplified (LR/SD  3 in 75% of the tumor tested). Two of them (GCT1 and GCT2) were also found overexpressed (LR/SD  2 in 75% of the tumor tested). All
of the ESTs on the array that mapped at 12p11-p12 are shown from the distal (top) to proximal (bottom) of 12p. The positions on the chromosomal arm (bp) and UniGene cluster number
(Hs.) are given. The expression array ratio values are given in the ratios column. The percentage of tumors showing significant amplification of a particular EST is given in the %DNA
column. The percentage of tumors showing significant amplification and overexpression of a particular EST is given in the %RNA column. For comparison, the last two columns show
the two-sample t-statistics computed following the approach described by Hughes et al. (26). The ranks are taken within the ESTs mapped at 12p11-p12; empty fields correspond to
insufficient data for determining the t-parameter. Notice that when using the t-statistics scheme, the two first candidates (green) are identical to the one found using our approach.
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18), encodes a protein that is expressed in adult ovary (follicle cells,
nurse cell, and oocyte) and in adult testis. GCT2 has five exons
spanning 14.5 Kb of genomic sequence. The ESTs were assembled
in a UniGene cluster Hs.62275 and a TIGR cluster THC758883 and
included cDNA derived from germ cells and GCTs. The correspond-
ing human hypothetical protein sequence (DKFZp761G2423.1, Gen-
Bank accession T46908) showed 60–91% identity with protein se-
quences of different species grouped in TOGA 102326 and TOGA
86129.
A RT-PCR analysis of a panel of human tissues was performed
using GCT1 and GCT2 primer pairs as described in “Materials and
Methods.” Both genes were expressed in all of the tissues tested,
including testis and ovary (Fig. 5). Their expression was then assayed
in a panel of 47 GCT samples by semiquantitative RT-PCR that
included 22 nonseminomas (10 cell lines and 12 tumor samples), 24
seminomas, and the OCCL cell line using the same primer pairs.
GCT1 was overexpressed compared with normal testis (1.27 to
2.83) in 92% of the seminomas and 18% of the nonseminomas and
the OGCT, whereas GCT2 was overexpressed (1.38 to 3.07) in
71% of the seminomas and 32% of the nonseminomas and the OGCT.
These data confirm that both amplified genes are overexpressed
Fig. 5. RT-PCR analyses of GCT1 and GCT2 in a tissue panel.
Fig. 3. Data normalization and identification of
significantly amplified and overexpressed genes.
Controls (placenta/placenta for CGH array and nor-
mal testis/normal testis for expression array) and
test (tumor/control) hybridizations in CGH and ex-
pression EST arrays are shown. A, the raw intensi-
ties. The blue lines indicate ratios of 0.5, 1, and 2.
B, the normalized data obtained from a local robust
regression. The red dots lie outside three local SDs
of the noise envelope in the CGH array experi-
ments and outside two in the expression array ex-
periments. C, quantile-quantile plots showing the
Gaussian distribution of the log ratios divided by
the local SD [YN/(XN)]. A perfectly straight line
implies perfect Gaussian behavior. The CGH array
experiment shows a clear excess of points on the
right side of the distribution (tail indicated by green
arrow), as anticipated from genomic amplification.
Fig. 4. Southern blot analyses of GCT1 and GCT2 in the 4 seminomas (427A, 187A,
287B, and 192A) and the OCCL with 12p11-p12 chromosomal amplification plus pla-
centa. Tumor 192A did not show amplification of GCT1, possibly indicating a partial
deletion. The copy number and relative gDNA amount per lane are given.
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significantly in seminomas and less so in nonseminomas. This is
consistent with the chromosomal CGH data, which showed 12p11-
p12 amplification predominantly in seminomas.
DISCUSSION
Increase of gene dosage by DNA amplification of chromosomal
regions is a frequent genetic alteration during tumorigenesis. There-
fore, a high throughput screening method for identification of ampli-
fied as well as overexpressed sequences is of considerable value for
the understanding of the molecular mechanisms of cancer, especially
those that underlie progression and clinical behavior. Several studies
have shown that many human neoplasms, including GCTs, exhibit
overrepresentation of 12p sequences. Chromosomal CGH analysis of
38 GCTs and the OCCL showed high-level amplification at 12p11-
p12 in 4 seminomas and in OCCL. We subjected these samples to a
combined array CGH and expression analysis using an array spotted
with 8254 ESTs. We found it important to normalize the data using a
local regression technique as systematic errors introduced by the
intensity-dependent dye efficiencies can lead to serious misinterpre-
tation of data when using global normalization. In addition, local
normalization is a necessary step before evaluating the local SD of the
log ratios, which we used as criteria for attributing significance of
variation. This criterion was justified because the log ratios divided by
the local SD showed close Gaussian distributions and enabled to
account for the intensity dependence of the noise clouds. Thus, a ratio
value may be considered as highly significant at the highest intensities
and insignificant toward the lower intensity end. The approach used
here shares some similarity with a previously published approach
(26), except that the local SD was determined in this analysis empir-
ically without an a priori noise model. Because of the relatively few
samples (four tumors and five controls) in the expression array, we
were reluctant to use a t-statistics-based approach as our primary
measure for identifying overexpressed ESTs. Nevertheless, the ranks
of the t-statistics, as reported in Fig. 2, show a good correlation with
results from the approach used. Merging data from five tumors, the
analysis scheme used lead to the identification of amplified ESTs
located at 12p11-p12, with very low false-positive rates. We found 13
ESTs with highly significant values (LR/SD  3) in 75% of the
tumors giving a high biological as well as statistical confidence to the
results. Two of these sequences (GCT1 and GCT2) were also over-
expressed in 75% of the tumor samples and therefore were consid-
ered as candidate amplified and overexpressed genes. We blasted (27)
the 33 ESTs mapped to 12p11-p12 against the human draft genome
sequences database (Homo sapiens build 24) and mapped them using
Entrez Genome Map Viewer.11 These two ESTs were mapped at23
and 29 Mb, respectively, from the distal 12p.
Several candidate genes on 12p have previously been studied or
suggested because of the overall copy number increase of this chro-
mosomal arm consistently associated with TGCTs. These included
SOX5, LRMP (JAW1), KRAS2, FGF6, TEL, CDKN1B (KIP1),
PTHLH, LDHB, TNFRSF1A (TNFR1), LGS, SSPN (KRAG), ITPR2,
CD69, CD94, GDF3, GRIN2B, PYGL, IAPP, and RECQL. The array
used by us contained ESTs representing ITPR2, PYGL, SSPN,
RECQL, TNFRSF1A, CDKN1B, TEL, KRAS2, and LRMP. Among
these, RECQL, ITPR2, KRAS2, and LRMP were found amplified;
however, none of them were overexpressed by array analysis.
The two amplified and overexpressed sequences identified in this
study were designated here as GCT1 and GCT2. These novel genes
code for hypothetical proteins without known functions. Both genes
were expressed in all normal human tissues tested, including testis and
ovary. In a semiquantitative RT-PCR analysis of 47 GCT samples,
both genes showed overexpression more frequently in seminomas
than in nonseminomas consistent with chromosomal CGH analysis.
These studies thus demonstrate the feasibility of identifying candi-
date amplified and overexpressed genes in large regions of chromo-
somal amplification using EST arrays and robust data analysis meth-
ods. They identified here, for the first time, two novel genes, mapped
at 12p, amplified and overexpressed. The elucidation of role of the
GCT1 and GCT2 in normal and tumor cell biology is in progress.
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